imatinib mesylate has been researched along with Brain Injuries in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Chen, G; Ding, J; Li, H; Li, X; Lian, J; Shen, H; Sun, Q; Wang, J; Yang, S | 1 |
Fujimoto, M; Imanaka-Yoshida, K; Kanamaru, K; Kawakita, F; Shiba, M; Suzuki, H; Taki, W; Yoshida, T | 1 |
Changlong, Z; Guangwei, Z; Xiaochuan, S; Xiaohui, X; Xuenong, H; Yanfeng, X | 1 |
3 other study(ies) available for imatinib mesylate and Brain Injuries
Article | Year |
---|---|
The role of Tenascin C in intracerebral hemorrhage-induced secondary brain injury in rats via induction of neuronal cell death and neuroinflammation.
Topics: Animals; Brain Injuries; Cell Death; Cerebral Hemorrhage; Disease Models, Animal; Imatinib Mesylate; Male; Neuroinflammatory Diseases; Rats; Rats, Sprague-Dawley; Tenascin | 2022 |
Effects of tenascin-C on early brain injury after subarachnoid hemorrhage in rats.
Topics: Animals; Benzamides; Brain Injuries; Disease Models, Animal; Imatinib Mesylate; In Situ Nick-End Labeling; Male; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Rats, Sprague-Dawley; Subarachnoid Hemorrhage; Tenascin; Up-Regulation | 2015 |
The Role of Platelet-Derived Growth Factor Receptor in Early Brain Injury Following Subarachnoid Hemorrhage.
Topics: Animals; Anthracenes; Antineoplastic Agents; Brain Edema; Brain Injuries; Caspase 3; Disease Models, Animal; Double-Blind Method; Enzyme Inhibitors; Gene Expression Regulation; Hippocampus; Imatinib Mesylate; In Situ Nick-End Labeling; Male; Platelet-Derived Growth Factor; Rats; Rats, Sprague-Dawley; Receptors, Platelet-Derived Growth Factor; RNA, Messenger; Subarachnoid Hemorrhage | 2016 |